Form 8-K - Current report:
SEC Accession No. 0001104659-10-064641
Filing Date
2010-12-29
Accepted
2010-12-29 16:40:36
Documents
8
Period of Report
2010-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-24344_18k.htm 8-K 54598
2 EX-1.1 a10-24344_1ex1d1.htm EX-1.1 127118
3 EX-4.1 a10-24344_1ex4d1.htm EX-4.1 109412
4 EX-5.1 a10-24344_1ex5d1.htm EX-5.1 20447
5 EX-10.1 a10-24344_1ex10d1.htm EX-10.1 203578
6 EX-99.1 a10-24344_1ex99d1.htm EX-99.1 15226
7 GRAPHIC g243441kc01i001.jpg GRAPHIC 5721
8 GRAPHIC g243441mmi001.jpg GRAPHIC 5368
  Complete submission text file 0001104659-10-064641.txt   547795
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 101278711
SIC: 2836 Biological Products, (No Diagnostic Substances)